Guillermo Garcia-Manero, MD
Professor and Dr. Kenneth B. McCredie Chair in Clinical Leukemia Research
Chief, Section of Myelodysplastic Syndromes
Department of Leukemia, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Guillermo Garcia-Manero, MD, is the Dr. Kenneth B. McCredie Chair in Clinical Leukemia Research in the Department of Leukemia at The University of Texas MD Anderson Cancer Center. He also serves as the chief of the Section of Myelodysplastic Syndromes, vice-chairman for Translational Research, leader of the MDS & AML Moon Shot program, and program director of the Leukemia Fellowship Program (September 2019). He recently was elected as chair-elect of the Faculty Senate of The University of Texas MD Anderson Cancer Center, which started in September 2019.
Dr Garcia-Manero was born in Spain and received his medical degree and training at the University of Zaragoza in Spain and at the Royal Free Hospital in London, UK. From 1993 to 1996, he performed his internship and residency in internal medicine at Thomas Jefferson University Hospital in Philadelphia, PA. He then continued his training with a fellowship in hematology and medical oncology at the Cardeza Foundation for Hematologic Research, Sidney Kimmel Cancer Center, also at Thomas Jefferson University Hospital, where he served as chief fellow. In 1999, he became assistant professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center, where he has remained.
Dr Garcia-Manero focuses on the understanding of the cellular and molecular biology of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) with an aim to improve therapeutic options for patients with these disorders. His work has been funded by the National Institutes of Health, the US Department of Defense, the Leukemia & Lymphoma Society, the Cancer Prevention and Research Institute of Texas, and the MDS & AML Moon Shot project. He has coauthored more than 682 manuscripts. His last H-index is 119 and his i10-Index is 630 with over 58,000 citations to his work. Currently, he is the principal investigator or co-principal investigator for more than 25 active clinical trials focusing on AML and MDS.
He directs what is likely the largest single institution unit for patients with MDS in the world, with more than 400 patients referred annually and maintains one of the busiest clinics at MD Anderson. The Section of MDS is comprised of leukemia faculty dedicated to the care of patients with MDS and 2 research laboratories directed by Dr Colla and Dr Wei. In addition, the section coordinates the work of more than 15 research nurses.
Dr Garcia-Manero has received a number of significant awards, such as The Otis W. and Pearl L. Walters Faculty Achievement Award in Clinical Research and the Emil J. Freireich Award for Excellence in Translational Research at MD Anderson. He has also been recognized as one of the Best Doctors in America each year since 2007. He has trained more than 100 fellows and postdoctoral fellows and has been a speaker at multiple national and international forums.